USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Vital Signs - Long-Term Weight Loss Treatments
Vital Signs - Long-Term Weight Loss Treatments
RELEASE DATE
08-Nov-2010
08-Nov-2010
REGION
North America
North America
Research Code: 9561-00-B4-00-00
SKU: HC00609-NA-MR_04082
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00609-NA-MR_04082
Description
This issue of Vital Signs, released on November 8, 2010, provides a strategic overview of key issues and trends relating to prescription medications for long-term weight loss. Additionally, a company spotlight is provided for Vitae Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on building a portfolio of novel, small molecule, best-in-class compounds that address large markets, including chronic kidney disease (CKD), diabetes and Alzheimer’s disease. Reimbursement and regulatory news from the FDA is also provided for the week of October 18, 2010.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on November 8, 2010, provides a strategic overview of key issues and trends relating to prescription medications for long-term weight loss. Additionally, a company spotlight is provided for Vitae Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on building a portfolio of novel, small molecule, best-in-class compounds that address large markets, including chronic kidney disease (CKD), diabetes and Alzheimers disease. Reimbursement and regulatory news from the FDA is also provided for the week of October 18, 2010.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | 9561-00-B4-00-00 |
| Is Prebook | No |